22:45:46 EDT Tue 04 Oct 2022
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Tilray Inc
Symbol TLRY
Shares Issued 446,156,841
Close 2021-10-25 C$ 13.66
Recent Sedar Documents

Tilray to supply pot to Luxembourg Ministry of Health

2021-10-26 10:30 ET - News Release

Mr. Irwin Simon reports

TILRAY EXPANDS MEDICAL CANNABIS FOOTPRINT IN EUROPE

Tilray Inc. has been selected by the Luxembourg Ministry of Health as a supplier of good manufacturing practice-certified medical cannabis products for the country's medical cannabis program.

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC (tetrahydrocannabinol) and CBD (cannabidiol) for patients with varying medical conditions. These prescription-based medical cannabis products will be administered to qualifying patients in Luxembourg under the supervision of physicians.

Irwin D. Simon, chairman and chief executive officer, stated: "We believe that Tilray's growth potential in the European Union represents a $1-billion opportunity, and today's announcement affirms that we are turning potential into performance. With today's validation from the Luxembourg Ministry of Health, Tilray now offers branded medical cannabis in 20 countries around the world -- a testament to our high standards and status as a trusted partner to patients in need. We're proud to be building this unrivalled global platform and will continue to advocate for patient access in Europe and countries around the world."

Denise Faltischek, head of international and chief strategy officer, added: "Tilray's mission includes an unwavering conviction that patients around the world should have access to safe, high-quality cannabinoid-based medicine. We're proud to expand this effort to Luxembourg and provide patients in need with pharmaceutical-grade medical cannabis products. We are committed to being a trusted partner, and we will continue to leverage our strong medical platform to increase access to the highest-quality medical cannabis for patients worldwide."

Tilray operates two state-of-the-art GMP-certified cannabis cultivation facilities in Europe located in Cantanhede, Portugal, and Neumunster, Germany. The EU campus in Portugal is a multifaceted production facility that includes the cultivation, extraction, processing and packaging of medical cannabis. It also serves as a hub supporting Tilray's clinical research and product development efforts across Europe. In addition, Tilray has established sales and distribution arrangements to supply medical cannabis through major pharmaceutical distribution channels, including CC Pharma, throughout Germany and the EU, which will serve as a means to allowing patients to access Tilray's GMP-certified finished medical cannabis.

About Tilray Inc.

Tilray is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America. Tilray is changing people's lives for the better -- one person at a time -- by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body and soul, and invoke a sense of well-being. Tilray's mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation and distribution, Tilray's unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and alcoholic beverages.

We seek Safe Harbor.

© 2022 Canjex Publishing Ltd. All rights reserved.